Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Astonishing Deserts All over The Planet You Really want To Visit - 2New portrait of the oldest-known supernova | Space photo of the day for March 27, 2026
- 3Hamas delegation meets Egypt’s spy chief amid mutual ceasefire violation claims
- 4FDA updates risk classification for voluntary shredded cheese recall
- 5Overlooked infertility care should be part of national health services, says WHO
- Find the Advantages of Innovative Leisure activities: Supporting Creative mind and Self-Articulation
- Cocoa Prices Sink on Favorable Crop Conditions in West Africa
- Computerized Domains d: A Survey of \Vivid Undertakings\ Computer generated Reality Game
- Involved Vehicles for Seniors: Track down the Best Picks for Solace and Unwavering quality
- Figure out How to Adjust Your Handshake to Various Societies
- Closets for Your Room: Plan and Utility Features
- Rick Steves Recommends This German Town's Castle Hotel With Rhine River Views
- Key Training: Picking a Significant for Monetary Achievement
- War in Iran could exacerbate German housing crisis, minister warns
